CD8A and cancer: Typically, cancers that respond well to targeted immune checkpoints are characterised by an immune microenvironment infiltrated with high numbers of immune cells and pro-inflammatory cytokines such as CD4+ T cells, CD8+ T cells, interferon (IFN), IL12, IL2, IL23 and TNF-alpha.